The Prisma Health Cancer Institute has expanded to offer new clinical facilities in Columbia to provide advanced specialty care for patients across the Midlands.
The Cancer Institute takes a new approach to treating cancer as a complex group of diseases that require consultation among surgical oncologists, medical and radiation oncologists, diagnostic radiologists, pathologists, and many other cancer specialists.
This expansion brings new offerings in early detection and diagnosis, cancer prevention, access to advanced treatment options and optimization of cancer survival support to the Midlands. The new location will also directly link to Prisma Health’s Institute for Translational Oncology Research; This gives providers the advanced ability to classify tumors and offer access to “precisely personalized” clinical trial options.
The Medical Director of Prisma Health Cancer Institute, Dr. Larry Gluck says the center will allow more opportunities for patient care.
This expansion to the Midlands will allow us to offer enhanced specialty and subspecialty expertise and robust clinical trial opportunities as part of the Prisma Health network
The Commission on Cancer (CoC), a program of the American College of Surgeons, has also granted accreditation to Prisma Health Cancer Institute’s oncology program in the Midlands. To earn this accreditation, a cancer program must meet 34 quality care standards, be evaluated every three years, and maintain levels of excellence in the delivery of comprehensive patient-centered care.
For more information on Prisma Health’s Cancer Institute or to find a location in the Upstate or Midlands, visit prismahealth.org.